Two FDA-approved products, PHEXX and SOLOSEC, are driving revenue growth and expanding globally, supported by strong IP and targeted marketing. Cost reduction initiatives and new international partnerships aim to boost profitability and broaden market reach.

Original document:

This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.